$123 Million is the total value of Burrage Capital Management LLC's 27 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 48.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PLX | Sell | PROTALIX BIOTHERAPEUTICS INC | $9,480,000 | +5.7% | 2,125,585 | -14.0% | 7.68% | +12.4% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $8,796,000 | +6.8% | 864,916 | -21.8% | 7.13% | +13.5% |
| MEIP | Sell | MEI PHARMA INC | $7,996,000 | -5.5% | 2,331,313 | -27.3% | 6.48% | +0.4% |
| PTCT | Sell | PTC THERAPEUTICS INC | $7,594,000 | -22.8% | 160,372 | -0.4% | 6.15% | -17.9% |
| NEO | Sell | NEOGENOMICS INC | $7,134,000 | -25.9% | 147,921 | -17.3% | 5.78% | -21.2% |
| EPIX | New | ESSA PHARMA INC | $6,898,000 | – | 237,442 | +100.0% | 5.59% | – |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $6,826,000 | -22.7% | 72,164 | -0.4% | 5.53% | -17.8% |
| CYTK | Sell | CYTOKINETICS INC | $5,691,000 | +11.3% | 244,673 | -0.6% | 4.61% | +18.3% |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $5,107,000 | +46.5% | 63,634 | -0.7% | 4.14% | +55.7% |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $4,956,000 | – | 150,000 | +100.0% | 4.02% | – |
| EPZM | Sell | EPIZYME INC | $4,917,000 | -51.3% | 564,555 | -39.3% | 3.98% | -48.3% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $4,162,000 | +31.6% | 272,393 | +21.5% | 3.37% | +40.0% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $4,080,000 | +44.6% | 205,866 | +27.4% | 3.31% | +53.7% |
| CARA | New | CARA THERAPEUTICS INC | $3,908,000 | – | 180,000 | +100.0% | 3.17% | – |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $3,767,000 | +18.3% | 319,819 | +17.6% | 3.05% | +25.8% |
| TCDA | New | TRICIDA INC | $3,485,000 | – | 658,877 | +100.0% | 2.82% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $3,464,000 | -25.6% | 80,727 | -0.8% | 2.81% | -20.9% |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $3,461,000 | -39.2% | 114,454 | -0.4% | 2.80% | -35.3% |
| INZY | Sell | INOZYME PHARMA INC | $3,356,000 | -4.8% | 169,473 | -0.8% | 2.72% | +1.2% |
| AVRO | Buy | AVROBIO INC | $3,108,000 | +53.0% | 244,920 | +68.1% | 2.52% | +62.7% |
| ADCT | Sell | ADC THERAPEUTICS SA | $3,048,000 | -24.3% | 124,875 | -0.8% | 2.47% | -19.5% |
| GERN | New | GERON CORP | $3,022,000 | – | 1,912,673 | +100.0% | 2.45% | – |
| GTHX | G1 THERAPEUTICS INC | $2,832,000 | +33.7% | 117,708 | 0.0% | 2.30% | +42.2% | |
| MRUS | MERUS N V | $2,730,000 | +19.2% | 130,683 | 0.0% | 2.21% | +26.7% | |
| BDTX | Buy | BLACK DIAMOND THERAPEUTICS I | $2,679,000 | +139.6% | 110,447 | +216.5% | 2.17% | +154.8% |
| New | TURNING POINT THERAPEUTICS I | $861,000 | – | 700 | +100.0% | 0.70% | – | |
| New | INTELLIA THERAPEUTICS INC | $46,000 | – | 630 | +100.0% | 0.04% | – | |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -15,006 | -100.0% | -0.10% | – |
| FREQ | Exit | FREQUENCY THERAPEUTICS INC | $0 | – | -124,650 | -100.0% | -3.35% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -336,384 | -100.0% | -3.55% | – |
| INSM | Exit | INSMED INC | $0 | – | -154,562 | -100.0% | -3.92% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -1,388,136 | -100.0% | -7.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EPIZYME INC COM | 7 | Q2 2021 | 15.9% |
| NeoGenomics Inc | 7 | Q2 2021 | 8.7% |
| OrthoPediatrics Corp | 7 | Q2 2021 | 7.3% |
| Y-MABS THERAPEUTICS INC COM | 7 | Q2 2021 | 4.3% |
| CRINETICS PHARMACEUTICALS INC COM | 7 | Q2 2021 | 5.6% |
| G1 THERAPEUTICS INC COM | 7 | Q2 2021 | 7.3% |
| PTC THERAPEUTICS INC COM | 6 | Q1 2021 | 8.0% |
| CYTOKINETICS INC COM NEW | 6 | Q2 2021 | 4.9% |
| TURNING PT THERAPEUTICS INC COM | 6 | Q2 2021 | 6.7% |
| APELLIS PHARMACEUTICALS INC COM | 6 | Q1 2021 | 3.5% |
View Burrage Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Protalix BioTherapeutics, Inc.Sold out | July 30, 2021 | 0 | 0.0% |
| IVERIC bio, Inc. | February 14, 2020 | 10 | 3.4% |
View Burrage Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| SC 13G/A | 2021-07-30 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-12 |
| SC 13G | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
View Burrage Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.